Novartis reports positive results from phase III trial of Kisqali for advanced or metastatic breast cancer December 07, 2017Vol.40 No.10
Phase III study shows Tecentriq and Avastin plus chemo reduced risk of disease progression or death in advanced lung cancer December 07, 2017Vol.40 No.10
Mount Sinai researchers develop first mathematical model for predicting patient response to immunotherapy December 07, 2017Vol.40 No.10
FDA approves Foundation Medicine’s genomic profiling test for all solid tumors; CMS proposes coverage December 01, 2017Vol.43 No.44By Matthew Bin Han Ong
NCI Sharpless lists initial priorities for NCI: Big Data, cell therapy, and more trials at the NIH Clinical Center December 01, 2017Vol.43 No.44By Matthew Bin Han Ong
Conversation with The Cancer Letter Caligiuri: It was time for me to hit the refresh button on my career November 28, 2017Vol.43 No.44By Matthew Bin Han Ong and Paul Goldberg
Caligiuri named president of City of Hope National Medical Center November 28, 2017Vol.43 No.44By Matthew Bin Han Ong and Paul Goldberg
FreeObituary Hail to “The Chief” Donald S. Coffey, a scientist, a mentor, a wit, dies at 85 November 17, 2017Vol.43 No.43By Kenneth J. Pienta
Caligiuri resigns as CEO of the James after stepping down as director of OSUCCC November 17, 2017Vol.43 No.43By Matthew Bin Han Ong
